U.S. MarketsAugust 4 at 06:30 AM

IDEXX Laboratories (IDXX) Q2 (USD): EPS 4.27 (exp. 3.94), Revenue 1.22bln (exp. 1.20bln), guides FY26 revenue between 4.7-4.75bln (exp. 4.71bln) and EPS between 14.69-14.94 (exp. 14.65)

StockNow breaking-news AI analysis

IDEXX beat Q2 earnings and revenue expectations today, reporting EPS of $4.27 and $1.22B revenue, driven by strong diagnostic recurring revenue despite macroeconomic headwinds in clinic visits.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

Geopolitics

The draft agreed to by Iranian and Omani negotiators awaits final approval from Iran’s supreme leader, two regional officials told The Associated Press on Wednesday

U.S. Economy